4 ms·
Maybe that’s fine? A company that can do cutting edge research and a company that can manufacture and market at scale don’t have to be the same company.
by xyzelement 3y ago
Maybe that’s fine? A company that can do cutting edge research and a company that can manufacture and market at scale don’t have to be the same company.
- sparrowInHand 3y agoThere is a invisible incentive filter though- nobody will create a startup that is not worth buying for a large company - or whos product would cannibalize somebody elses product in the oligopoly.
- xyzelement 3y agoI am not sure that's true (is it?) but more so, don't see how that follows from Pharma's alleged focus on acquisition. Can you give me an example where in a different world something good would happen that isn't happening now and why? I am not trying to be difficult just genuine don't see it yet.
- deleted 3y ago[deleted]
- rustymonday 3y agoYou're right. More and more pharmaceutical manufacturing is contracted out to CDMOs. So one day big pharma might only do marketing.